Technical Analysis for CTX - Crescita Therapeutics Inc.

Grade Last Price % Change Price Change
D 0.435 0.00% 0.000
CTX closed unchanged on Friday, April 19, 2024, on 21 percent of normal volume.
Earnings due: May 9
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Flat

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
MACD Bullish Centerline Cross Bullish 0.00%
Narrow Range Bar Range Contraction 0.00%
Gapped Up Strength 0.00%
MACD Bearish Centerline Cross Bearish 3.57%
Narrow Range Bar Range Contraction 3.57%
Narrow Range Bar Range Contraction 3.57%
New Downtrend Bearish 3.57%
Narrow Range Bar Range Contraction 3.57%
Gapped Down Weakness 3.57%

   Recent Intraday Alerts

Alert Time
Rose Above 10 DMA about 23 hours ago
Rose Above Previous Day's High 2 days ago
Rose Above 10 DMA 2 days ago
Up 3% 2 days ago
Up 2% 2 days ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Crescita Therapeutics Inc. Description

Crescita Therapeutics Inc. is a drug development company. The Company owns products for treating medical conditions in dermatology and pain. It owns various drug delivery platforms, which include Durapeel and Foam technology to support the development of patented formulations that can deliver actives into or through the skin. It operates two business units: the Topical Products and Technology (TPT) Group and the Immunology Group. The TPT Group product, Pliaglis and other products are focused on dermatology and pain. Its product Flexicaine is in Phase II clinical stage and has therapeutic area in Tick-borne disease. Its product Ibuprofen Foam is in pre-clinical stage and has therapeutic area in Acute Pain. Its product Terbinafine is in pre-clinical stage and has therapeutic area in Onychomycosis. Its product Mical 1 is in pre-clinical stage and has therapeutic area in Psoriasis. Its product Mical 2 is in pre-clinical stage and has therapeutic area in Dermatological skin treatment.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Delivery Clinic Drug Pain Disease RTT Drugs Skin Medical Specialties Organ Systems Immunology Drug Delivery Drug Development Acute Pain Dermatology Psoriasis Onychomycosis Topical Products

Is CTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.79
52 Week Low 0.36
Average Volume 17,819
200-Day Moving Average 0.563
50-Day Moving Average 0.443
20-Day Moving Average 0.420
10-Day Moving Average 0.434
Average True Range 0.014
RSI (14) 52.38
ADX 21.46
+DI 42.440
-DI 35.585
Chandelier Exit (Long, 3 ATRs) 0.447
Chandelier Exit (Short, 3 ATRs) 0.403
Upper Bollinger Bands 0.468
Lower Bollinger Band 0.372
Percent B (%b) 0.65
BandWidth 22.841
MACD Line 0.001
MACD Signal Line -0.002
MACD Histogram 0.0026
Fundamentals Value
Market Cap 8.98 Million
Num Shares 20.6 Million
EPS 0.01
Price-to-Earnings (P/E) Ratio 62.14
Price-to-Sales 1.08
Price-to-Book 0.77
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.435
Resistance 3 (R3) 0.435 0.435 0.435
Resistance 2 (R2) 0.435 0.435 0.435 0.435
Resistance 1 (R1) 0.435 0.435 0.435 0.435 0.435
Pivot Point 0.435 0.435 0.435 0.435 0.435
Support 1 (S1) 0.435 0.435 0.435 0.435 0.435
Support 2 (S2) 0.435 0.435 0.435 0.435
Support 3 (S3) 0.435 0.435 0.435
Support 4 (S4) 0.435